8VSJ: Engineered peptide-specific binder
Engineered peptide-specific binder in complex with HLA-DR1/CLIP. Determined by electron microscopy at 2.28 Å resolution. Released 2 Oct 2024.
- Method
- Electron microscopy
- Resolution
- 2.28 Å
- Organisms
- Homo sapiens, Metamycoplasma arthritidis
- Chains
- 6
- Atoms
- 5,832
- Mol. weight
- 108.78 kDa
- Ligands
- NAG
- Released
- 2 Oct 2024
Explore 8VSJ in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
8VSJ contains 20 α-helices and 54 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 5 helices, 16 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 2-13 | 12 | 1 |
| β-strand | 17-24 | 8 | 1 |
| β-strand | 27-33 | 7 | 1 |
| β-strand | 38-41 | 4 | 1 |
| α-helix | 44-48 | 5 | |
| β-strand | 51 | 1 | 2 |
| α-helix | 54-57 | 4 | |
| α-helix | 58-74 | 17 | |
| α-helix | 78-81 | 4 | |
| β-strand | 83 | 1 | 3 |
| α-helix | 84-85 | 2 | |
| β-strand | 86-91 | 6 | 4 |
| β-strand | 101-110 | 10 | 4 |
| β-strand | 111 | 1 | 3 |
| β-strand | 118-121 | 4 | 5 |
| β-strand | 124-126 | 3 | 5 |
| β-strand | 131-132 | 2 | 4 |
| β-strand | 136 | 1 | 4 |
| β-strand | 143-151 | 9 | 4 |
| β-strand | 159-163 | 5 | 5 |
| β-strand | 172-176 | 5 | 5 |
Chain B: 6 helices, 15 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 186-197 | 12 | 1 |
| β-strand | 202-211 | 10 | 1 |
| β-strand | 214-220 | 7 | 1 |
| β-strand | 225-228 | 4 | 1 |
| α-helix | 234-240 | 7 | |
| α-helix | 244-251 | 8 | |
| α-helix | 253 | 1 | |
| α-helix | 254-259 | 6 | |
| α-helix | 260-265 | 6 | |
| β-strand | 274 | 1 | 6 |
| β-strand | 277-283 | 7 | 7 |
| β-strand | 292-301 | 10 | 7 |
| β-strand | 302 | 1 | 6 |
| β-strand | 308-312 | 5 | 8 |
| β-strand | 315-317 | 3 | 8 |
| β-strand | 321-323 | 3 | 7 |
| β-strand | 327-328 | 2 | 7 |
| β-strand | 334-340 | 7 | 7 |
| β-strand | 350-354 | 5 | 8 |
| α-helix | 362 | 1 | |
| β-strand | 363-367 | 5 | 8 |
Chain C: 6 helices, 0 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 3-5 | 3 | |
| α-helix | 24-25 | 2 | |
| α-helix | 26-34 | 9 | |
| α-helix | 42-65 | 24 | |
| α-helix | 69-88 | 20 | |
| α-helix | 93-119 | 27 | |
Chain H: 2 helices, 10 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 9 |
| β-strand | 18-25 | 8 | 9 |
| β-strand | 32-39 | 8 | 10 |
| β-strand | 46-51 | 6 | 10 |
| β-strand | 57-59 | 3 | 10 |
| β-strand | 67-72 | 6 | 9 |
| β-strand | 77-82 | 6 | 9 |
| α-helix | 84-86 | 3 | |
| β-strand | 88-96 | 9 | 10 |
| α-helix | 100C | 1 | |
| β-strand | 100D-103 | 4 | 10 |
| β-strand | 107-109 | 3 | 10 |
Chain L: 1 helix, 12 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-6 | 3 | 11 |
| β-strand | 10-13 | 4 | 12 |
| β-strand | 19-25 | 7 | 11 |
| β-strand | 33-38 | 6 | 12 |
| β-strand | 44-46 | 3 | 12 |
| β-strand | 48-49 | 2 | 13 |
| β-strand | 53-54 | 2 | 13 |
| β-strand | 62-67 | 6 | 11 |
| β-strand | 70-75 | 6 | 11 |
| β-strand | 85-90 | 6 | 12 |
| α-helix | 96 | 1 | |
| β-strand | 97-98 | 2 | 12 |
| β-strand | 102-106 | 5 | 12 |
Chain P: 0 helices, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4 | 1 | 2 |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| HLA class II histocompatibility antigen, DR alpha chain | A | protein | 184 | Homo sapiens | P01903 (AlphaFold model) |
| HLA class II histocompatibility antigen DR beta chain | B | protein | 192 | Homo sapiens | D7RIG0 (AlphaFold model) |
| Superantigen | C | protein | 129 | Metamycoplasma arthritidis | Q48898 (AlphaFold model) |
| c44H10 Fab heavy chain | H | protein | 223 | Homo sapiens | |
| c44H10 Fab light chain | L | protein | 214 | Homo sapiens | |
| Class-II-associated invariant chain peptide | P | protein | 15 | Homo sapiens | P04233 (AlphaFold model) |
Sequence of entity 1 (A), FASTA
>8VSJ_1 HLA class II histocompatibility antigen, DR alpha chain (chains A)
IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGAL
ANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVT
WLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEF
DASR
Sequence of entity 2 (B), FASTA
>8VSJ_2 HLA class II histocompatibility antigen DR beta chain (chains B)
GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEY
WNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSV
TSPLTVEWRASR
Sequence of entity 3 (C), FASTA
>8VSJ_3 Superantigen (chains C)
MKLRCENPKKASIYLAQNLNNVVFTNKELEDIYDLSNKEETKEVLKKFKEKVNQFYRHAF
DIINKYGDKEVFNMMFLKLSVVFDIQRKEANNVEQIKRNIATLDEIMAKADNDLCYFISQ
WLEHHHHHH
Sequence of entity 4 (H), FASTA
>8VSJ_4 c44H10 Fab heavy chain (chains H)
QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSINYN
SALMSRLSISKDNFKSQVFLKMSSLQTDDTAMYYCARAYGDYVHYAMDYWGQGTSVTASS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
Sequence of entity 5 (L), FASTA
>8VSJ_5 c44H10 Fab light chain (chains L)
DIQMTQSPSSLSASLGQRVSLTCRASQEISGYLTWLQQKPDGTIKRLVYAASTLDSGVPK
RFSGSRSGSDYSLTISSLESEDFADYYCLQYTNYPLTFGAGTKLELKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
Sequence of entity 6 (P), FASTA
>8VSJ_6 Class-II-associated invariant chain peptide (chains P)
PVSKMRMATPLLMQA
Ligands and cofactors
| ID | Name | Formula | Copies |
|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | C8 H15 N O6 | 3 |
Primary citation
A general system for targeting MHC class II-antigen complex via a single adaptable loop. Du, H., Liu, J., Jude, K.M. et al. Nat Biotechnol (2025) 43:1673-1682. DOI 10.1038/s41587-024-02466-y · PubMed
Other PDB entries of the same protein (UniProt P01903 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 5NI9 1.33 Å, Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340
- 4X5W 1.34 Å, HLA-DR1 with CLIP102-120(M107W)
- 5NIG 1.35 Å, Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340…
- 8CMC 1.42 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530
- 8PJF 1.48 Å, Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified influenza A…
- 6QZC 1.64 Å, HLA-DR1 with the QAR Peptide
- 8CMG 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide…
- 8CMH 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike…
- 4MD5 1.65 Å, Immune Receptor
- 4MDJ 1.7 Å, Immune Receptor
- 8PJE 1.7 Å, Human Leukocyte Antigen class II allotype DR1 presenting influenza A virus…
- 7YX9 1.76 Å, MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange
Browse structure collections
About this viewer
MolViewer shows 8VSJ directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.